Matt Altman

Matt Altman is a seasoned executive with extensive experience in leadership roles across various organizations. Currently serving as Managing Partner at Arlington Capital Partners since August 2001, Matt also holds multiple chairman positions, including Millstone Medical, Grand River Aseptic Manufacturing, and Riverpoint Medical. Additionally, Matt is a member of the Board of Advisors at Duke Cancer Institute and has served on the boards of several companies, including Everest Clinical Research, Molecular Products, Ontario Systems, Endeavor Robotics, and United Flexible. Matt's academic background includes an MBA from Stanford University Graduate School of Business and a BA in Economics from Duke University.